

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.18199244 |
| 2 | * L-phenylalanine catabolic process (GO:0006559) | 7.18199244 |
| 3 | * erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.82249510 |
| 4 | * L-phenylalanine metabolic process (GO:0006558) | 6.82249510 |
| 5 | * aromatic amino acid family catabolic process (GO:0009074) | 6.37496636 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.97224838 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.74846322 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.74846322 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.74846322 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 5.62469641 |
| 11 | glyoxylate metabolic process (GO:0046487) | 5.60680631 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.55736098 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.54931272 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.45662616 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 5.32693001 |
| 16 | cysteine metabolic process (GO:0006534) | 5.28300534 |
| 17 | urea metabolic process (GO:0019627) | 5.23045487 |
| 18 | urea cycle (GO:0000050) | 5.23045487 |
| 19 | complement activation, alternative pathway (GO:0006957) | 5.11576414 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.06331066 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.03936532 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.00150534 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.93030106 |
| 24 | protein carboxylation (GO:0018214) | 4.93030106 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 4.88525093 |
| 26 | regulation of fibrinolysis (GO:0051917) | 4.85286316 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.83792639 |
| 28 | regulation of protein activation cascade (GO:2000257) | 4.83347194 |
| 29 | bile acid metabolic process (GO:0008206) | 4.80166260 |
| 30 | lysine catabolic process (GO:0006554) | 4.76875764 |
| 31 | lysine metabolic process (GO:0006553) | 4.76875764 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.72139118 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.67088048 |
| 34 | acylglycerol homeostasis (GO:0055090) | 4.63565865 |
| 35 | triglyceride homeostasis (GO:0070328) | 4.63565865 |
| 36 | * aromatic amino acid family metabolic process (GO:0009072) | 4.58487558 |
| 37 | amino-acid betaine metabolic process (GO:0006577) | 4.58242634 |
| 38 | regulation of complement activation (GO:0030449) | 4.52818541 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.49190624 |
| 40 | * alpha-amino acid catabolic process (GO:1901606) | 4.46729891 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.45848779 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.42544234 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.42544234 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.42544234 |
| 45 | cellular ketone body metabolic process (GO:0046950) | 4.40186485 |
| 46 | plasma lipoprotein particle clearance (GO:0034381) | 4.38580907 |
| 47 | coenzyme catabolic process (GO:0009109) | 4.18841196 |
| 48 | protein complex biogenesis (GO:0070271) | 4.18725314 |
| 49 | * cellular amino acid catabolic process (GO:0009063) | 4.18405526 |
| 50 | phospholipid efflux (GO:0033700) | 4.18259820 |
| 51 | indolalkylamine metabolic process (GO:0006586) | 4.13458096 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.13048807 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.13048807 |
| 54 | * tyrosine metabolic process (GO:0006570) | 4.12843567 |
| 55 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.11027391 |
| 56 | exogenous drug catabolic process (GO:0042738) | 4.05749164 |
| 57 | glutamate metabolic process (GO:0006536) | 4.00525552 |
| 58 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.99716984 |
| 59 | ATP synthesis coupled proton transport (GO:0015986) | 3.99716984 |
| 60 | bile acid and bile salt transport (GO:0015721) | 3.99458562 |
| 61 | glycine metabolic process (GO:0006544) | 3.99301302 |
| 62 | cellular biogenic amine catabolic process (GO:0042402) | 3.98904445 |
| 63 | amine catabolic process (GO:0009310) | 3.98904445 |
| 64 | serine family amino acid metabolic process (GO:0009069) | 3.98011070 |
| 65 | short-chain fatty acid metabolic process (GO:0046459) | 3.97463899 |
| 66 | acetyl-CoA metabolic process (GO:0006084) | 3.97074180 |
| 67 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.96192861 |
| 68 | ethanol oxidation (GO:0006069) | 3.95541460 |
| 69 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.95527225 |
| 70 | cellular modified amino acid catabolic process (GO:0042219) | 3.94558096 |
| 71 | cellular glucuronidation (GO:0052695) | 3.92893308 |
| 72 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.91969765 |
| 73 | imidazole-containing compound metabolic process (GO:0052803) | 3.91404431 |
| 74 | benzene-containing compound metabolic process (GO:0042537) | 3.90097485 |
| 75 | fatty acid beta-oxidation (GO:0006635) | 3.88014011 |
| 76 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.86159137 |
| 77 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.86159137 |
| 78 | NADH dehydrogenase complex assembly (GO:0010257) | 3.86159137 |
| 79 | cholesterol efflux (GO:0033344) | 3.84791301 |
| 80 | drug catabolic process (GO:0042737) | 3.84082434 |
| 81 | fatty acid oxidation (GO:0019395) | 3.81777693 |
| 82 | * organic acid catabolic process (GO:0016054) | 3.81019810 |
| 83 | * carboxylic acid catabolic process (GO:0046395) | 3.81019810 |
| 84 | ketone body metabolic process (GO:1902224) | 3.80717379 |
| 85 | positive regulation of lipid catabolic process (GO:0050996) | 3.79157944 |
| 86 | valine metabolic process (GO:0006573) | 3.78498329 |
| 87 | aldehyde catabolic process (GO:0046185) | 3.77648544 |
| 88 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.76477678 |
| 89 | lipid oxidation (GO:0034440) | 3.74550321 |
| 90 | serine family amino acid biosynthetic process (GO:0009070) | 3.73798731 |
| 91 | monocarboxylic acid catabolic process (GO:0072329) | 3.72268841 |
| 92 | fatty acid catabolic process (GO:0009062) | 3.69265865 |
| 93 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.68863925 |
| 94 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.68737922 |
| 95 | plasma lipoprotein particle assembly (GO:0034377) | 3.68099607 |
| 96 | 2-oxoglutarate metabolic process (GO:0006103) | 3.66720078 |
| 97 | behavioral response to nicotine (GO:0035095) | 3.66688323 |
| 98 | arginine metabolic process (GO:0006525) | 3.66593834 |
| 99 | phospholipid homeostasis (GO:0055091) | 3.65795684 |
| 100 | respiratory chain complex IV assembly (GO:0008535) | 3.64804734 |
| 101 | negative regulation of lipase activity (GO:0060192) | 3.64086378 |
| 102 | low-density lipoprotein particle remodeling (GO:0034374) | 3.63577785 |
| 103 | drug transmembrane transport (GO:0006855) | 3.59161430 |
| 104 | fibrinolysis (GO:0042730) | 3.59093635 |
| 105 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.59073775 |
| 106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.59073775 |
| 107 | oxidative demethylation (GO:0070989) | 3.58209751 |
| 108 | cholesterol homeostasis (GO:0042632) | 3.57607090 |
| 109 | regulation of cholesterol homeostasis (GO:2000188) | 3.55199632 |
| 110 | glucuronate metabolic process (GO:0019585) | 3.52472934 |
| 111 | uronic acid metabolic process (GO:0006063) | 3.52472934 |
| 112 | cofactor catabolic process (GO:0051187) | 3.52405953 |
| 113 | sterol homeostasis (GO:0055092) | 3.52241085 |
| 114 | electron transport chain (GO:0022900) | 3.51487405 |
| 115 | aspartate family amino acid catabolic process (GO:0009068) | 3.50822875 |
| 116 | carnitine metabolic process (GO:0009437) | 3.50055163 |
| 117 | respiratory electron transport chain (GO:0022904) | 3.49560426 |
| 118 | cytochrome complex assembly (GO:0017004) | 3.37035089 |
| 119 | platelet dense granule organization (GO:0060155) | 3.36019719 |
| 120 | regulation of mitochondrial translation (GO:0070129) | 3.24900447 |
| 121 | rRNA modification (GO:0000154) | 3.24673352 |
| 122 | omega-hydroxylase P450 pathway (GO:0097267) | 3.17756604 |
| 123 | peptidyl-histidine modification (GO:0018202) | 3.09072771 |
| 124 | protein-cofactor linkage (GO:0018065) | 3.07056268 |
| 125 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.05290818 |
| 126 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.05290818 |
| 127 | epoxygenase P450 pathway (GO:0019373) | 3.04647732 |
| 128 | ribosomal small subunit assembly (GO:0000028) | 2.98694244 |
| 129 | L-methionine salvage (GO:0071267) | 2.94304750 |
| 130 | L-methionine biosynthetic process (GO:0071265) | 2.94304750 |
| 131 | amino acid salvage (GO:0043102) | 2.94304750 |
| 132 | inner mitochondrial membrane organization (GO:0007007) | 2.92727782 |
| 133 | base-excision repair, AP site formation (GO:0006285) | 2.86577622 |
| 134 | rRNA methylation (GO:0031167) | 2.86315320 |
| 135 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.85478929 |
| 136 | termination of RNA polymerase III transcription (GO:0006386) | 2.85478929 |
| 137 | mannosylation (GO:0097502) | 2.84539325 |
| 138 | viral transcription (GO:0019083) | 2.84265040 |
| 139 | translational termination (GO:0006415) | 2.82808199 |
| 140 | ATP biosynthetic process (GO:0006754) | 2.76841785 |
| 141 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.75891539 |
| 142 | maturation of 5.8S rRNA (GO:0000460) | 2.75422981 |
| 143 | branched-chain amino acid catabolic process (GO:0009083) | 2.75062154 |
| 144 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.74292308 |
| 145 | GTP biosynthetic process (GO:0006183) | 2.72882426 |
| 146 | ubiquinone biosynthetic process (GO:0006744) | 2.72110264 |
| 147 | nucleotide transmembrane transport (GO:1901679) | 2.68432176 |
| 148 | pseudouridine synthesis (GO:0001522) | 2.67799244 |
| 149 | chaperone-mediated protein transport (GO:0072321) | 2.67504286 |
| 150 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.64879313 |
| 151 | vitamin biosynthetic process (GO:0009110) | 2.64063660 |
| 152 | regulation of hexokinase activity (GO:1903299) | 2.62890427 |
| 153 | regulation of glucokinase activity (GO:0033131) | 2.62890427 |
| 154 | protein neddylation (GO:0045116) | 2.61609662 |
| 155 | S-adenosylmethionine metabolic process (GO:0046500) | 2.60964514 |
| 156 | DNA deamination (GO:0045006) | 2.60352256 |
| 157 | hydrogen ion transmembrane transport (GO:1902600) | 2.58833553 |
| 158 | xenobiotic catabolic process (GO:0042178) | 2.57421291 |
| 159 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.56273198 |
| 160 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.56228314 |
| 161 | ubiquinone metabolic process (GO:0006743) | 2.54797808 |
| 162 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.54224305 |
| 163 | proteasome assembly (GO:0043248) | 2.52256852 |
| 164 | cotranslational protein targeting to membrane (GO:0006613) | 2.51953201 |
| 165 | endosome to melanosome transport (GO:0035646) | 2.51853052 |
| 166 | endosome to pigment granule transport (GO:0043485) | 2.51853052 |
| 167 | intracellular protein transmembrane import (GO:0044743) | 2.49890506 |
| 168 | drug metabolic process (GO:0017144) | 2.49577092 |
| 169 | proton transport (GO:0015992) | 2.49026369 |
| 170 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.46983657 |
| 171 | protein targeting to ER (GO:0045047) | 2.46531823 |
| 172 | ribosomal small subunit biogenesis (GO:0042274) | 2.46232241 |
| 173 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.45925744 |
| 174 | translational elongation (GO:0006414) | 2.45522008 |
| 175 | hydrogen transport (GO:0006818) | 2.45086656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.11956242 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.93842906 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.50233396 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.33810296 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.20163405 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.10183365 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.92319977 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.94336507 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.87065501 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.84355759 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.78555264 |
| 12 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.32358703 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.27405873 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.16061997 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.98073761 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.73203304 |
| 17 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.66069406 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.63322379 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.47424988 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.37743017 |
| 21 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.33419196 |
| 22 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.14632539 |
| 23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06494591 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.04253974 |
| 25 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.00045041 |
| 26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.3227423 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.97535208 |
| 28 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.93416291 |
| 29 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.91777913 |
| 30 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.81379102 |
| 31 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.77336752 |
| 32 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.77037194 |
| 33 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.76795217 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.72490911 |
| 35 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.68005939 |
| 36 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.66389877 |
| 37 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.63873507 |
| 38 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.62537358 |
| 39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58855823 |
| 40 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.54668391 |
| 41 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.52390191 |
| 42 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.51694740 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.48970312 |
| 44 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.48285542 |
| 45 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.47571381 |
| 46 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39123478 |
| 47 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.38263133 |
| 48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.34452570 |
| 49 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.34187488 |
| 50 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.33969038 |
| 51 | EWS_26573619_Chip-Seq_HEK293_Human | 1.33843620 |
| 52 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.33156921 |
| 53 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.33156921 |
| 54 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.33066776 |
| 55 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.32198244 |
| 56 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.30765390 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30711977 |
| 58 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.30580022 |
| 59 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25911738 |
| 60 | ERA_21632823_ChIP-Seq_H3396_Human | 1.25584023 |
| 61 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.24661598 |
| 62 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.24608647 |
| 63 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.23706772 |
| 64 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20316026 |
| 65 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.19936646 |
| 66 | FUS_26573619_Chip-Seq_HEK293_Human | 1.19096560 |
| 67 | * HOXB7_26014856_ChIP-Seq_BT474_Human | 1.18665768 |
| 68 | NCOR_22424771_ChIP-Seq_293T_Human | 1.17913851 |
| 69 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.17845362 |
| 70 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.15143054 |
| 71 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.13771337 |
| 72 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.12114425 |
| 73 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.12014103 |
| 74 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.11697957 |
| 75 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.10699193 |
| 76 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10661462 |
| 77 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.10595565 |
| 78 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.09078405 |
| 79 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.08465778 |
| 80 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.08361932 |
| 81 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.04254717 |
| 82 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.03660124 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03426405 |
| 84 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02962598 |
| 85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02731545 |
| 86 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.00236821 |
| 87 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98654885 |
| 88 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.98544937 |
| 89 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.97505410 |
| 90 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.96852769 |
| 91 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.96552641 |
| 92 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.95149208 |
| 93 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94296219 |
| 94 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.93883376 |
| 95 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92813559 |
| 96 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.92092275 |
| 97 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.89523821 |
| 98 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.89101910 |
| 99 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89076625 |
| 100 | P300_19829295_ChIP-Seq_ESCs_Human | 0.88916368 |
| 101 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.88594024 |
| 102 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.88489787 |
| 103 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87942470 |
| 104 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.87752193 |
| 105 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.87718061 |
| 106 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.87672608 |
| 107 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.87550381 |
| 108 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87298807 |
| 109 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.87038611 |
| 110 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.87038611 |
| 111 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86851607 |
| 112 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.86842893 |
| 113 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.86107748 |
| 114 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.85634763 |
| 115 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.83343444 |
| 116 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82232066 |
| 117 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81105578 |
| 118 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79732905 |
| 119 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78117435 |
| 120 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71690333 |
| 121 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71690333 |
| 122 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71325915 |
| 123 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.70645043 |
| 124 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.70149005 |
| 125 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.69705917 |
| 126 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69291607 |
| 127 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.69023338 |
| 128 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.68504070 |
| 129 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67989437 |
| 130 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.67541806 |
| 131 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.67178923 |
| 132 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66431118 |
| 133 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65279745 |
| 134 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.62839861 |
| 135 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62251975 |
| 136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.61660727 |
| 137 | AR_20517297_ChIP-Seq_VCAP_Human | 0.61515621 |
| 138 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.61085697 |
| 139 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.60705408 |
| 140 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.60404063 |
| 141 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.60194514 |
| 142 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60181239 |
| 143 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58070279 |
| 144 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.56905969 |
| 145 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.54850401 |
| 146 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53225324 |
| 147 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52301546 |
| 148 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50853829 |
| 149 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.50805607 |
| 150 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.50720935 |
| 151 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50150421 |
| 152 | GATA1_19941826_ChIP-Seq_K562_Human | 0.49381249 |
| 153 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48361180 |
| 154 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48093318 |
| 155 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.48059947 |
| 156 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.47986645 |
| 157 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.47821847 |
| 158 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.47367971 |
| 159 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47159796 |
| 160 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.47008100 |
| 161 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46781261 |
| 162 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.46389303 |
| 163 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.45913805 |
| 164 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.44417163 |
| 165 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.44089325 |
| 166 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43045260 |
| 167 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.42890852 |
| 168 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42588228 |
| 169 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42508008 |
| 170 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.41596491 |
| 171 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41508237 |
| 172 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.41118584 |
| 173 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.40641387 |
| 174 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.40195911 |
| 175 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.39766095 |
| 176 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.39099397 |
| 177 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.38568974 |
| 178 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.38177096 |
| 179 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.38177096 |
| 180 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.37450976 |
| 181 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.37369677 |
| 182 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.36970975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.07956512 |
| 2 | MP0005360_urolithiasis | 7.25042237 |
| 3 | MP0005365_abnormal_bile_salt | 6.05088203 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.96393128 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.85479412 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.05025050 |
| 7 | MP0003252_abnormal_bile_duct | 3.73358126 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.68804676 |
| 9 | MP0003195_calcinosis | 3.01889970 |
| 10 | MP0009840_abnormal_foam_cell | 2.95903901 |
| 11 | MP0005332_abnormal_amino_acid | 2.91066175 |
| 12 | MP0005083_abnormal_biliary_tract | 2.77699747 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.50914130 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.40988659 |
| 15 | MP0003646_muscle_fatigue | 2.40936265 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.28655430 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.23264090 |
| 18 | * MP0000609_abnormal_liver_physiology | 2.16340653 |
| 19 | MP0006292_abnormal_olfactory_placode | 2.16081612 |
| 20 | MP0003136_yellow_coat_color | 2.10692913 |
| 21 | MP0003718_maternal_effect | 2.00189505 |
| 22 | MP0009379_abnormal_foot_pigmentation | 1.98839860 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.98347175 |
| 24 | MP0002653_abnormal_ependyma_morphology | 1.96916880 |
| 25 | MP0005670_abnormal_white_adipose | 1.92001473 |
| 26 | MP0005646_abnormal_pituitary_gland | 1.88420312 |
| 27 | MP0005551_abnormal_eye_electrophysiolog | 1.87233878 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.85873053 |
| 29 | MP0001764_abnormal_homeostasis | 1.79655706 |
| 30 | MP0003868_abnormal_feces_composition | 1.77116666 |
| 31 | MP0000372_irregular_coat_pigmentation | 1.75305888 |
| 32 | MP0003693_abnormal_embryo_hatching | 1.71872663 |
| 33 | MP0002938_white_spotting | 1.70549763 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.63345510 |
| 35 | MP0002160_abnormal_reproductive_system | 1.52266741 |
| 36 | MP0002102_abnormal_ear_morphology | 1.51645893 |
| 37 | * MP0009643_abnormal_urine_homeostasis | 1.46655118 |
| 38 | MP0006072_abnormal_retinal_apoptosis | 1.43834392 |
| 39 | MP0009697_abnormal_copulation | 1.43473373 |
| 40 | MP0008877_abnormal_DNA_methylation | 1.41143810 |
| 41 | MP0005075_abnormal_melanosome_morpholog | 1.37929422 |
| 42 | MP0001986_abnormal_taste_sensitivity | 1.37101377 |
| 43 | MP0002876_abnormal_thyroid_physiology | 1.34979096 |
| 44 | MP0004142_abnormal_muscle_tone | 1.33761671 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.32281849 |
| 46 | MP0004133_heterotaxia | 1.31292268 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.31191861 |
| 48 | MP0008058_abnormal_DNA_repair | 1.30056108 |
| 49 | MP0000427_abnormal_hair_cycle | 1.27866269 |
| 50 | MP0005451_abnormal_body_composition | 1.27751750 |
| 51 | * MP0003186_abnormal_redox_activity | 1.26737367 |
| 52 | MP0004130_abnormal_muscle_cell | 1.24416189 |
| 53 | MP0002163_abnormal_gland_morphology | 1.24070976 |
| 54 | MP0001293_anophthalmia | 1.23212660 |
| 55 | MP0001968_abnormal_touch/_nociception | 1.23187596 |
| 56 | MP0002638_abnormal_pupillary_reflex | 1.21052835 |
| 57 | * MP0002837_dystrophic_cardiac_calcinosis | 1.19713071 |
| 58 | MP0003011_delayed_dark_adaptation | 1.19403421 |
| 59 | MP0005389_reproductive_system_phenotype | 1.14785034 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.13981334 |
| 61 | MP0005666_abnormal_adipose_tissue | 1.12704878 |
| 62 | * MP0000598_abnormal_liver_morphology | 1.11873681 |
| 63 | MP0005253_abnormal_eye_physiology | 1.10907014 |
| 64 | MP0005636_abnormal_mineral_homeostasis | 1.08383966 |
| 65 | MP0005647_abnormal_sex_gland | 1.08155081 |
| 66 | MP0002078_abnormal_glucose_homeostasis | 1.07913861 |
| 67 | MP0002971_abnormal_brown_adipose | 1.07451361 |
| 68 | MP0005377_hearing/vestibular/ear_phenot | 1.07182276 |
| 69 | MP0003878_abnormal_ear_physiology | 1.07182276 |
| 70 | MP0005410_abnormal_fertilization | 1.06426901 |
| 71 | MP0006036_abnormal_mitochondrial_physio | 1.06048865 |
| 72 | MP0002736_abnormal_nociception_after | 1.04618377 |
| 73 | MP0009046_muscle_twitch | 1.03475041 |
| 74 | MP0003705_abnormal_hypodermis_morpholog | 1.03304376 |
| 75 | MP0005334_abnormal_fat_pad | 1.01782548 |
| 76 | MP0001661_extended_life_span | 1.01573260 |
| 77 | MP0004147_increased_porphyrin_level | 1.00843771 |
| 78 | MP0005174_abnormal_tail_pigmentation | 1.00153348 |
| 79 | MP0001485_abnormal_pinna_reflex | 1.00068063 |
| 80 | MP0005535_abnormal_body_temperature | 0.97573257 |
| 81 | MP0000604_amyloidosis | 0.96131285 |
| 82 | MP0009764_decreased_sensitivity_to | 0.94262462 |
| 83 | MP0002210_abnormal_sex_determination | 0.94006949 |
| 84 | MP0002254_reproductive_system_inflammat | 0.92438069 |
| 85 | * MP0009763_increased_sensitivity_to | 0.91676785 |
| 86 | MP0009642_abnormal_blood_homeostasis | 0.91616404 |
| 87 | MP0001756_abnormal_urination | 0.90884340 |
| 88 | MP0003890_abnormal_embryonic-extraembry | 0.90617907 |
| 89 | MP0005220_abnormal_exocrine_pancreas | 0.90052978 |
| 90 | MP0000631_abnormal_neuroendocrine_gland | 0.89967810 |
| 91 | MP0005195_abnormal_posterior_eye | 0.89868896 |
| 92 | MP0005084_abnormal_gallbladder_morpholo | 0.89495361 |
| 93 | MP0003119_abnormal_digestive_system | 0.88882748 |
| 94 | MP0001919_abnormal_reproductive_system | 0.88404281 |
| 95 | MP0000383_abnormal_hair_follicle | 0.86958062 |
| 96 | MP0005408_hypopigmentation | 0.83997097 |
| 97 | MP0002277_abnormal_respiratory_mucosa | 0.83991940 |
| 98 | MP0008469_abnormal_protein_level | 0.83633153 |
| 99 | MP0003698_abnormal_male_reproductive | 0.83319466 |
| 100 | MP0001929_abnormal_gametogenesis | 0.82514459 |
| 101 | MP0003283_abnormal_digestive_organ | 0.82461270 |
| 102 | MP0010030_abnormal_orbit_morphology | 0.80981982 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.80554391 |
| 104 | MP0004043_abnormal_pH_regulation | 0.80403805 |
| 105 | MP0002095_abnormal_skin_pigmentation | 0.79850260 |
| 106 | MP0002751_abnormal_autonomic_nervous | 0.79636387 |
| 107 | MP0002234_abnormal_pharynx_morphology | 0.79598470 |
| 108 | MP0010368_abnormal_lymphatic_system | 0.78694024 |
| 109 | MP0001145_abnormal_male_reproductive | 0.78640584 |
| 110 | MP0000653_abnormal_sex_gland | 0.78402498 |
| 111 | MP0003690_abnormal_glial_cell | 0.77971130 |
| 112 | MP0005448_abnormal_energy_balance | 0.77509108 |
| 113 | MP0003567_abnormal_fetal_cardiomyocyte | 0.75702761 |
| 114 | MP0000026_abnormal_inner_ear | 0.75100299 |
| 115 | MP0010094_abnormal_chromosome_stability | 0.73535216 |
| 116 | MP0001905_abnormal_dopamine_level | 0.73319222 |
| 117 | MP0001324_abnormal_eye_pigmentation | 0.72807990 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.72723443 |
| 119 | MP0005266_abnormal_metabolism | 0.67834940 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.65882149 |
| 121 | MP0004185_abnormal_adipocyte_glucose | 0.63820879 |
| 122 | MP0003724_increased_susceptibility_to | 0.62432553 |
| 123 | MP0009115_abnormal_fat_cell | 0.62161629 |
| 124 | MP0003953_abnormal_hormone_level | 0.61460179 |
| 125 | MP0003329_amyloid_beta_deposits | 0.59437738 |
| 126 | MP0002136_abnormal_kidney_physiology | 0.58555173 |
| 127 | MP0002970_abnormal_white_adipose | 0.57942927 |
| 128 | MP0000639_abnormal_adrenal_gland | 0.57779582 |
| 129 | MP0006035_abnormal_mitochondrial_morpho | 0.54955172 |
| 130 | MP0004782_abnormal_surfactant_physiolog | 0.54842023 |
| 131 | MP0002928_abnormal_bile_duct | 0.54605890 |
| 132 | MP0003959_abnormal_lean_body | 0.53111308 |
| 133 | MP0000230_abnormal_systemic_arterial | 0.51403356 |
| 134 | MP0001944_abnormal_pancreas_morphology | 0.50729425 |
| 135 | MP0005058_abnormal_lysosome_morphology | 0.50115900 |
| 136 | MP0005395_other_phenotype | 0.46160162 |
| 137 | MP0009672_abnormal_birth_weight | 0.45377780 |
| 138 | MP0002168_other_aberrant_phenotype | 0.44014582 |
| 139 | MP0003638_abnormal_response/metabolism_ | 0.43461962 |
| 140 | MP0000013_abnormal_adipose_tissue | 0.40593293 |
| 141 | MP0009053_abnormal_anal_canal | 0.40307242 |
| 142 | MP0001765_abnormal_ion_homeostasis | 0.39589659 |
| 143 | MP0001881_abnormal_mammary_gland | 0.37104694 |
| 144 | MP0005452_abnormal_adipose_tissue | 0.36171668 |
| 145 | MP0008874_decreased_physiological_sensi | 0.35791749 |
| 146 | MP0005464_abnormal_platelet_physiology | 0.35456979 |
| 147 | MP0008873_increased_physiological_sensi | 0.34905236 |
| 148 | MP0002796_impaired_skin_barrier | 0.34632535 |
| 149 | MP0003075_altered_response_to | 0.34466606 |
| 150 | MP0004264_abnormal_extraembryonic_tissu | 0.34415696 |
| 151 | MP0009780_abnormal_chondrocyte_physiolo | 0.33738358 |
| 152 | MP0008872_abnormal_physiological_respon | 0.32676192 |
| 153 | MP0000249_abnormal_blood_vessel | 0.30459741 |
| 154 | MP0000003_abnormal_adipose_tissue | 0.30421372 |
| 155 | MP0005379_endocrine/exocrine_gland_phen | 0.30218854 |
| 156 | MP0002060_abnormal_skin_morphology | 0.30127288 |
| 157 | MP0002822_catalepsy | 0.29881995 |
| 158 | MP0005248_abnormal_Harderian_gland | 0.27729361 |
| 159 | MP0002693_abnormal_pancreas_physiology | 0.26637236 |
| 160 | MP0008438_abnormal_cutaneous_collagen | 0.26617467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.16859217 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.65298753 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.57365007 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.00950062 |
| 5 | Xanthomatosis (HP:0000991) | 5.99137648 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.91038255 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.72013794 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.31653405 |
| 9 | Complement deficiency (HP:0004431) | 5.06997564 |
| 10 | Ketosis (HP:0001946) | 4.67138433 |
| 11 | Hyperammonemia (HP:0001987) | 4.64239862 |
| 12 | Hyperglycinemia (HP:0002154) | 4.55416232 |
| 13 | Hypoglycemic coma (HP:0001325) | 4.53001305 |
| 14 | Hyperglycinuria (HP:0003108) | 4.51152307 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.47375675 |
| 16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.33518033 |
| 17 | Abnormality of glycine metabolism (HP:0010895) | 4.33518033 |
| 18 | Joint hemorrhage (HP:0005261) | 4.32004609 |
| 19 | Epidermoid cyst (HP:0200040) | 4.31835633 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.17385389 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.14424545 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 4.09551155 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 4.07574660 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.99844881 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.97620136 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.90704184 |
| 27 | Acute encephalopathy (HP:0006846) | 3.90435559 |
| 28 | Acute necrotizing encephalopathy (HP:0006965) | 3.90109498 |
| 29 | Pancreatic cysts (HP:0001737) | 3.80312881 |
| 30 | Mitochondrial inheritance (HP:0001427) | 3.78399761 |
| 31 | Ketoacidosis (HP:0001993) | 3.76713933 |
| 32 | Fat malabsorption (HP:0002630) | 3.76302586 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.71654150 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.67492564 |
| 35 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.65267106 |
| 36 | Abnormality of complement system (HP:0005339) | 3.62433311 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.62016404 |
| 38 | Pancreatic fibrosis (HP:0100732) | 3.58353489 |
| 39 | Conjugated hyperbilirubinemia (HP:0002908) | 3.52892947 |
| 40 | Increased CSF lactate (HP:0002490) | 3.52016702 |
| 41 | True hermaphroditism (HP:0010459) | 3.42875126 |
| 42 | Lipid accumulation in hepatocytes (HP:0006561) | 3.40791780 |
| 43 | Hepatic necrosis (HP:0002605) | 3.40664499 |
| 44 | Hypercholesterolemia (HP:0003124) | 3.40397029 |
| 45 | Hepatocellular necrosis (HP:0001404) | 3.38718429 |
| 46 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.31370835 |
| 47 | Hyperbilirubinemia (HP:0002904) | 3.20878695 |
| 48 | Progressive macrocephaly (HP:0004481) | 3.14322409 |
| 49 | Increased hepatocellular lipid droplets (HP:0006565) | 3.13646709 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 3.13234497 |
| 51 | Hypoglycemic seizures (HP:0002173) | 3.10687798 |
| 52 | Abnormality of serum amino acid levels (HP:0003112) | 3.10683016 |
| 53 | Delayed CNS myelination (HP:0002188) | 3.08682813 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 3.04166329 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.97597747 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.97597747 |
| 57 | Metabolic acidosis (HP:0001942) | 2.93342770 |
| 58 | Renal Fanconi syndrome (HP:0001994) | 2.92867141 |
| 59 | Gout (HP:0001997) | 2.90810063 |
| 60 | Skin nodule (HP:0200036) | 2.80433934 |
| 61 | Hepatocellular carcinoma (HP:0001402) | 2.79263838 |
| 62 | Steatorrhea (HP:0002570) | 2.79023859 |
| 63 | Abnormality of midbrain morphology (HP:0002418) | 2.79017463 |
| 64 | Molar tooth sign on MRI (HP:0002419) | 2.79017463 |
| 65 | Lethargy (HP:0001254) | 2.78981185 |
| 66 | Congenital stationary night blindness (HP:0007642) | 2.75691246 |
| 67 | Abnormal number of erythroid precursors (HP:0012131) | 2.75624521 |
| 68 | Myocardial infarction (HP:0001658) | 2.74830599 |
| 69 | Reticulocytopenia (HP:0001896) | 2.74671613 |
| 70 | Generalized aminoaciduria (HP:0002909) | 2.73050084 |
| 71 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.62906856 |
| 72 | Increased serum lactate (HP:0002151) | 2.60525022 |
| 73 | Sclerocornea (HP:0000647) | 2.58518225 |
| 74 | Cerebral edema (HP:0002181) | 2.58062346 |
| 75 | 3-Methylglutaconic aciduria (HP:0003535) | 2.53231595 |
| 76 | Spontaneous abortion (HP:0005268) | 2.53012308 |
| 77 | Reduced antithrombin III activity (HP:0001976) | 2.52831955 |
| 78 | Systemic lupus erythematosus (HP:0002725) | 2.52320353 |
| 79 | Lactic acidosis (HP:0003128) | 2.51878479 |
| 80 | Chronic hepatic failure (HP:0100626) | 2.51603618 |
| 81 | Nephronophthisis (HP:0000090) | 2.51310300 |
| 82 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.51159801 |
| 83 | Methylmalonic aciduria (HP:0012120) | 2.50604267 |
| 84 | Pendular nystagmus (HP:0012043) | 2.46666491 |
| 85 | Abnormal biliary tract physiology (HP:0012439) | 2.44573503 |
| 86 | Bile duct proliferation (HP:0001408) | 2.44573503 |
| 87 | Late onset (HP:0003584) | 2.43814298 |
| 88 | Cystic liver disease (HP:0006706) | 2.42281957 |
| 89 | Irritability (HP:0000737) | 2.40194137 |
| 90 | Hypochromic microcytic anemia (HP:0004840) | 2.39486420 |
| 91 | Increased intramyocellular lipid droplets (HP:0012240) | 2.38804881 |
| 92 | Vascular calcification (HP:0004934) | 2.38183131 |
| 93 | Abnormal gallbladder morphology (HP:0012437) | 2.37036042 |
| 94 | Type II lissencephaly (HP:0007260) | 2.36604931 |
| 95 | Type I transferrin isoform profile (HP:0003642) | 2.36359034 |
| 96 | Pancreatitis (HP:0001733) | 2.35845358 |
| 97 | Vomiting (HP:0002013) | 2.30335883 |
| 98 | Enlarged kidneys (HP:0000105) | 2.29916003 |
| 99 | Methylmalonic acidemia (HP:0002912) | 2.29393942 |
| 100 | Abnormality of the renal cortex (HP:0011035) | 2.27179888 |
| 101 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.26067776 |
| 102 | Abnormality of alanine metabolism (HP:0010916) | 2.26067776 |
| 103 | Hyperalaninemia (HP:0003348) | 2.26067776 |
| 104 | Spastic diplegia (HP:0001264) | 2.25619375 |
| 105 | Brushfield spots (HP:0001088) | 2.24803989 |
| 106 | Cholelithiasis (HP:0001081) | 2.23473764 |
| 107 | Respiratory failure (HP:0002878) | 2.21636496 |
| 108 | Increased muscle lipid content (HP:0009058) | 2.21520604 |
| 109 | Proximal tubulopathy (HP:0000114) | 2.21198250 |
| 110 | Acanthocytosis (HP:0001927) | 2.20513280 |
| 111 | Malnutrition (HP:0004395) | 2.20499059 |
| 112 | Neonatal onset (HP:0003623) | 2.20465693 |
| 113 | Symptomatic seizures (HP:0011145) | 2.19349731 |
| 114 | Hyperglycemia (HP:0003074) | 2.18797137 |
| 115 | Mitral stenosis (HP:0001718) | 2.18167135 |
| 116 | Medial flaring of the eyebrow (HP:0010747) | 2.17727501 |
| 117 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.16669947 |
| 118 | Abnormal protein glycosylation (HP:0012346) | 2.15396817 |
| 119 | Abnormal glycosylation (HP:0012345) | 2.15396817 |
| 120 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.15396817 |
| 121 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.15396817 |
| 122 | Male pseudohermaphroditism (HP:0000037) | 2.14668947 |
| 123 | Abnormality of proline metabolism (HP:0010907) | 2.14548919 |
| 124 | Hydroxyprolinuria (HP:0003080) | 2.14548919 |
| 125 | Sensorimotor neuropathy (HP:0007141) | 2.14311133 |
| 126 | Glomerulonephritis (HP:0000099) | 2.13919136 |
| 127 | Cardiovascular calcification (HP:0011915) | 2.12046183 |
| 128 | Amyloidosis (HP:0011034) | 2.11629902 |
| 129 | Optic disc pallor (HP:0000543) | 2.11339119 |
| 130 | Hyperuricemia (HP:0002149) | 2.10605159 |
| 131 | Increased purine levels (HP:0004368) | 2.10605159 |
| 132 | Alkalosis (HP:0001948) | 2.08081243 |
| 133 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.08017530 |
| 134 | Large for gestational age (HP:0001520) | 2.07714803 |
| 135 | Opisthotonus (HP:0002179) | 2.07437551 |
| 136 | Renal cortical cysts (HP:0000803) | 2.06174496 |
| 137 | Cholecystitis (HP:0001082) | 2.05701704 |
| 138 | Abnormal gallbladder physiology (HP:0012438) | 2.05701704 |
| 139 | Abnormality of the renal medulla (HP:0100957) | 2.03910593 |
| 140 | Hemorrhage of the eye (HP:0011885) | 2.03573695 |
| 141 | Hypertriglyceridemia (HP:0002155) | 2.02876947 |
| 142 | Furrowed tongue (HP:0000221) | 2.02645563 |
| 143 | Abnormality of urine glucose concentration (HP:0011016) | 2.01957210 |
| 144 | Glycosuria (HP:0003076) | 2.01957210 |
| 145 | Hyperventilation (HP:0002883) | 2.01704602 |
| 146 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.01318119 |
| 147 | Congenital hepatic fibrosis (HP:0002612) | 2.00995070 |
| 148 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.99781829 |
| 149 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.99781829 |
| 150 | Anencephaly (HP:0002323) | 1.99211918 |
| 151 | Severe muscular hypotonia (HP:0006829) | 1.97621486 |
| 152 | Abnormality of renal resorption (HP:0011038) | 1.96162858 |
| 153 | Concave nail (HP:0001598) | 1.96078025 |
| 154 | Abnormal cartilage morphology (HP:0002763) | 1.94927424 |
| 155 | Abnormality of the gallbladder (HP:0005264) | 1.92420364 |
| 156 | Esophageal varix (HP:0002040) | 1.92089074 |
| 157 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.91140761 |
| 158 | Absent thumb (HP:0009777) | 1.89820792 |
| 159 | Menorrhagia (HP:0000132) | 1.89627234 |
| 160 | Rickets (HP:0002748) | 1.88742093 |
| 161 | Elevated hepatic transaminases (HP:0002910) | 1.86256276 |
| 162 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.85909842 |
| 163 | Tubular atrophy (HP:0000092) | 1.84833428 |
| 164 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.83908908 |
| 165 | CNS demyelination (HP:0007305) | 1.83815203 |
| 166 | Polydipsia (HP:0001959) | 1.83172655 |
| 167 | Abnormal drinking behavior (HP:0030082) | 1.83172655 |
| 168 | Gingival bleeding (HP:0000225) | 1.82958240 |
| 169 | Hyperphosphaturia (HP:0003109) | 1.82095463 |
| 170 | Chromsome breakage (HP:0040012) | 1.81618333 |
| 171 | Nausea (HP:0002018) | 1.81022269 |
| 172 | Exercise intolerance (HP:0003546) | 1.79517786 |
| 173 | Anophthalmia (HP:0000528) | 1.79211452 |
| 174 | Abolished electroretinogram (ERG) (HP:0000550) | 1.76831519 |
| 175 | Hypoplasia of the pons (HP:0012110) | 1.75191323 |
| 176 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.74650840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.44308526 |
| 2 | SIK1 | 4.68415473 |
| 3 | VRK2 | 4.51917489 |
| 4 | ERN1 | 4.18239190 |
| 5 | INSRR | 4.08926601 |
| 6 | FGFR4 | 3.83150444 |
| 7 | ACVR1B | 3.46952017 |
| 8 | ZAK | 3.13643032 |
| 9 | TLK1 | 2.91050914 |
| 10 | STK16 | 2.68507631 |
| 11 | TAOK3 | 2.67625930 |
| 12 | BMPR1B | 2.48126578 |
| 13 | TRIB3 | 2.40435911 |
| 14 | ADRBK2 | 2.29885391 |
| 15 | MST1R | 2.21845357 |
| 16 | VRK1 | 2.17892238 |
| 17 | ERBB4 | 2.14765759 |
| 18 | FLT3 | 2.10086356 |
| 19 | NME2 | 2.09626882 |
| 20 | PIK3CG | 1.99293097 |
| 21 | TAF1 | 1.91903623 |
| 22 | FRK | 1.87386454 |
| 23 | MAP2K4 | 1.86855864 |
| 24 | CAMK1D | 1.83612106 |
| 25 | NUAK1 | 1.83194756 |
| 26 | MUSK | 1.80619173 |
| 27 | PKN2 | 1.79305221 |
| 28 | MAPK15 | 1.67785351 |
| 29 | STK39 | 1.65543170 |
| 30 | MAPK11 | 1.63623781 |
| 31 | MST4 | 1.54431984 |
| 32 | PHKG2 | 1.52349919 |
| 33 | PHKG1 | 1.52349919 |
| 34 | BUB1 | 1.51640477 |
| 35 | MAP4K2 | 1.50654613 |
| 36 | PASK | 1.47163874 |
| 37 | NME1 | 1.45911322 |
| 38 | CDK19 | 1.35051913 |
| 39 | PRKAA2 | 1.32495487 |
| 40 | LATS1 | 1.31274494 |
| 41 | NEK9 | 1.29566338 |
| 42 | PTK6 | 1.29266669 |
| 43 | FGFR2 | 1.28736379 |
| 44 | PINK1 | 1.28324640 |
| 45 | MAP2K7 | 1.21204374 |
| 46 | MAP3K4 | 1.20242570 |
| 47 | STK38L | 1.19663852 |
| 48 | NEK2 | 1.18388489 |
| 49 | LIMK1 | 1.18249914 |
| 50 | WNK3 | 1.17369763 |
| 51 | TYK2 | 1.15186145 |
| 52 | ABL2 | 1.14657493 |
| 53 | IRAK3 | 1.14134362 |
| 54 | MAPKAPK3 | 1.12886555 |
| 55 | DYRK2 | 1.11979857 |
| 56 | PDK4 | 1.11424777 |
| 57 | PDK3 | 1.11424777 |
| 58 | JAK2 | 1.10257671 |
| 59 | CAMK1G | 1.09976396 |
| 60 | WNK4 | 1.09245885 |
| 61 | PRKCI | 1.08315691 |
| 62 | CDC7 | 1.05354304 |
| 63 | CASK | 1.04879806 |
| 64 | MET | 1.03437827 |
| 65 | DAPK2 | 1.02969498 |
| 66 | CSNK1G3 | 0.98954351 |
| 67 | RPS6KB2 | 0.96343880 |
| 68 | TGFBR1 | 0.93916883 |
| 69 | MAP3K3 | 0.92063589 |
| 70 | EIF2AK3 | 0.91175274 |
| 71 | KDR | 0.90834917 |
| 72 | NEK1 | 0.90090266 |
| 73 | MAP3K7 | 0.88944106 |
| 74 | JAK1 | 0.88823098 |
| 75 | TIE1 | 0.88576374 |
| 76 | PIM2 | 0.88199269 |
| 77 | CHEK2 | 0.86544803 |
| 78 | MAP2K3 | 0.85917682 |
| 79 | PRKAA1 | 0.84646995 |
| 80 | PLK4 | 0.82873109 |
| 81 | ADRBK1 | 0.82139604 |
| 82 | CSNK1G2 | 0.81188850 |
| 83 | EPHA2 | 0.79749575 |
| 84 | PRKACG | 0.79138930 |
| 85 | PLK1 | 0.78053103 |
| 86 | PRKCZ | 0.75210040 |
| 87 | GSK3A | 0.74751710 |
| 88 | ATR | 0.74064173 |
| 89 | CSNK1A1L | 0.73192894 |
| 90 | AURKA | 0.72615502 |
| 91 | ERBB2 | 0.71686566 |
| 92 | RPS6KA5 | 0.71135730 |
| 93 | IKBKB | 0.70425494 |
| 94 | CDK6 | 0.69178185 |
| 95 | RIPK1 | 0.68724577 |
| 96 | MAPK4 | 0.68231549 |
| 97 | MAP3K12 | 0.67224074 |
| 98 | EPHB1 | 0.66043141 |
| 99 | TBK1 | 0.65615713 |
| 100 | FGFR3 | 0.64706732 |
| 101 | BRSK2 | 0.64706309 |
| 102 | SGK3 | 0.64224801 |
| 103 | EPHA3 | 0.63644601 |
| 104 | DYRK1B | 0.63406064 |
| 105 | TNK2 | 0.63133327 |
| 106 | PBK | 0.62180267 |
| 107 | PDPK1 | 0.62104880 |
| 108 | PRKCE | 0.60352754 |
| 109 | MAPKAPK5 | 0.59164955 |
| 110 | PLK3 | 0.58090715 |
| 111 | TRIM28 | 0.57570910 |
| 112 | MAP3K14 | 0.55988177 |
| 113 | CSK | 0.55793620 |
| 114 | MAPK12 | 0.54738544 |
| 115 | CAMK2G | 0.54657220 |
| 116 | SGK494 | 0.54242037 |
| 117 | SGK223 | 0.54242037 |
| 118 | MAP2K1 | 0.53828191 |
| 119 | TGFBR2 | 0.53088421 |
| 120 | CHUK | 0.52358958 |
| 121 | SGK2 | 0.52176792 |
| 122 | PTK2 | 0.51985620 |
| 123 | IGF1R | 0.51020516 |
| 124 | IRAK1 | 0.50874879 |
| 125 | CSNK1A1 | 0.50874351 |
| 126 | STK3 | 0.49344926 |
| 127 | GRK6 | 0.48280008 |
| 128 | PIK3CA | 0.45797364 |
| 129 | TESK1 | 0.45436665 |
| 130 | ILK | 0.44940444 |
| 131 | AURKB | 0.44831786 |
| 132 | EIF2AK1 | 0.44653030 |
| 133 | MAP3K11 | 0.44513762 |
| 134 | MAP3K2 | 0.44243865 |
| 135 | PDK2 | 0.44025416 |
| 136 | MAP2K6 | 0.44014010 |
| 137 | EIF2AK2 | 0.43523226 |
| 138 | MKNK2 | 0.41740262 |
| 139 | CSNK1G1 | 0.41310680 |
| 140 | IRAK2 | 0.41044571 |
| 141 | TNIK | 0.40901234 |
| 142 | DAPK3 | 0.40418325 |
| 143 | MAPK13 | 0.40167298 |
| 144 | CSNK2A1 | 0.39484808 |
| 145 | TESK2 | 0.38528830 |
| 146 | PAK3 | 0.38368800 |
| 147 | MTOR | 0.37744162 |
| 148 | RET | 0.37610047 |
| 149 | MAPK7 | 0.37389427 |
| 150 | MAP3K6 | 0.37370120 |
| 151 | MAP3K10 | 0.37098257 |
| 152 | PDK1 | 0.36867471 |
| 153 | PRKCQ | 0.35087105 |
| 154 | CSNK2A2 | 0.34868586 |
| 155 | TTK | 0.34430791 |
| 156 | DAPK1 | 0.33718694 |
| 157 | EPHB2 | 0.32806247 |
| 158 | MYLK | 0.31960644 |
| 159 | GRK1 | 0.31723860 |
| 160 | OBSCN | 0.31609399 |
| 161 | STK11 | 0.30094570 |
| 162 | PDGFRA | 0.29722828 |
| 163 | MAP3K1 | 0.29088317 |
| 164 | CSF1R | 0.28801627 |
| 165 | ATM | 0.28455853 |
| 166 | OXSR1 | 0.28078032 |
| 167 | FER | 0.27574003 |
| 168 | MAP3K5 | 0.25860511 |
| 169 | PRKCH | 0.25644230 |
| 170 | AKT3 | 0.23274605 |
| 171 | PRKCA | 0.23191177 |
| 172 | PRKACA | 0.22737123 |
| 173 | CDK4 | 0.22381610 |
| 174 | LMTK2 | 0.21809734 |
| 175 | PRKCG | 0.21753242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.14230880 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.36918880 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.19351663 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.01125577 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.99898073 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.82048418 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.71737942 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.70328260 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69438786 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.67269448 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.65150939 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.46827933 |
| 13 | Ribosome_Homo sapiens_hsa03010 | 2.46201867 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.45807661 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.34325910 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 2.32140137 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.31716817 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.21945565 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.18890076 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.09144227 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.06198571 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.03246865 |
| 23 | RNA polymerase_Homo sapiens_hsa03020 | 1.86148498 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83479932 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.82880869 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.79775444 |
| 27 | Homologous recombination_Homo sapiens_hsa03440 | 1.78661619 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.78331354 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.76544094 |
| 30 | Huntingtons disease_Homo sapiens_hsa05016 | 1.73931929 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.71570640 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.70065639 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.69747141 |
| 34 | Proteasome_Homo sapiens_hsa03050 | 1.69609905 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.66542551 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66179435 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61901847 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.61694440 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.60579634 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.59344123 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.56444304 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56231936 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.55548074 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53901752 |
| 45 | Alzheimers disease_Homo sapiens_hsa05010 | 1.53467829 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46738329 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.45022651 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.40657507 |
| 49 | Bile secretion_Homo sapiens_hsa04976 | 1.38941750 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30249532 |
| 51 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28713345 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.28080282 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 1.26080761 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.25652132 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23670625 |
| 56 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.22274012 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21430202 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 1.17998778 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15739528 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.13291165 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07804992 |
| 62 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.06419060 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.04956333 |
| 64 | Basal transcription factors_Homo sapiens_hsa03022 | 1.04040451 |
| 65 | Phototransduction_Homo sapiens_hsa04744 | 0.98469552 |
| 66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98219931 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.97914559 |
| 68 | Base excision repair_Homo sapiens_hsa03410 | 0.97492898 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96375662 |
| 70 | Mismatch repair_Homo sapiens_hsa03430 | 0.95903838 |
| 71 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95173684 |
| 72 | DNA replication_Homo sapiens_hsa03030 | 0.94368538 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92549679 |
| 74 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.92445532 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.91151838 |
| 76 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90002792 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89126829 |
| 78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86871768 |
| 79 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.86555488 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.83163331 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82878922 |
| 82 | RNA degradation_Homo sapiens_hsa03018 | 0.80725726 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80718457 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76311652 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74789129 |
| 86 | Purine metabolism_Homo sapiens_hsa00230 | 0.73912035 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67134156 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62665421 |
| 89 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.58780315 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56459653 |
| 91 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.54369300 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.51676429 |
| 93 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50750200 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50280533 |
| 95 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.50279498 |
| 96 | RNA transport_Homo sapiens_hsa03013 | 0.45599540 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44481412 |
| 98 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44339257 |
| 99 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.42834098 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41992689 |
| 101 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37576360 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35691694 |
| 103 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35153246 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.33915926 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33566544 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30919672 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.28069811 |
| 108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27800881 |
| 109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.22942612 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21337331 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20789459 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.18837279 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.11521459 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.00653702 |
| 115 | Hepatitis C_Homo sapiens_hsa05160 | -0.1973105 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1913461 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1631151 |
| 118 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1591367 |
| 119 | Lysosome_Homo sapiens_hsa04142 | -0.1549518 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1485864 |
| 121 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1453267 |
| 122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1452503 |
| 123 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1181133 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1106685 |
| 125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1042665 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0728565 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0659657 |
| 128 | Protein export_Homo sapiens_hsa03060 | -0.0619124 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0594617 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0576078 |
| 131 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0405477 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0105665 |
| 133 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0095380 |

